Skip to main content

STARLIGHT CARDIOVASCULAR, INC.

SAN DIEGO, California

Total Received

$6.2M

Total Awards

4

State

California

Last Updated

Feb 9, 2026

Yearly Funding Trend

Top 4 Awards to STARLIGHT CARDIOVASCULAR, INC.

Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through February 9, 2026.

Download CSV
Top 4 Awards to STARLIGHT CARDIOVASCULAR, INC.
AwardAwarding AgencyProgramPlaceFYObligation
ASST_NON_R44HL158304_075
DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY - ABSTRACT THE TECHNICAL CHALLENGES FACED BY PEDIATRIC CARDIOVASCULAR PHYSICIANS (SURGEONS AND INTERVENTIONALI…
Department of Health and Human Services
National Institutes of Health
93.837
CARDIOVASCULAR DISEASES RESEARCH
CA-902025$3,158,101
ASST_NON_R44HL162218_075
DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME - ABSTRACT STARLIGHT CARDIOVASCULAR IS DEVELOPING WHAT WILL BE THE FIRST FDA APPROVED PERCUTANEOUS F…
Department of Health and Human Services
National Institutes of Health
93.837
CARDIOVASCULAR DISEASES RESEARCH
SAN DIEGO, CA-512024$2,088,353
ASST_NON_SB1HL176266_075
COMMERCIALIZATION READINESS FOR DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY - ABSTRACT THE TECHNICAL CHALLENGES FACED BY PEDIATRIC CARDIOVASCULAR PHYSICIA…
Department of Health and Human Services
National Institutes of Health
93.837
CARDIOVASCULAR DISEASES RESEARCH
CA-902024$500,000
ASST_NON_R43HL162218_075
DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME - ABSTRACT STARLIGHT CARDIOVASCULAR IS DEVELOPING WHAT WILL BE THE FIRST FDA APPROVED PERCUTANEOUS F…
Department of Health and Human Services
National Institutes of Health
93.837
CARDIOVASCULAR DISEASES RESEARCH
SAN DIEGO, CA-512024$448,000

Top 4 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.